Chronic cough, defined as a cough persisting for more than eight weeks, is a common and often challenging condition encountered in clinical practice. It can significantly impair quality of life and may indicate serious underlying pathology. The diagnostic approach to chronic cough can be complex, necessitating comprehensive evaluation and management strategies.
Common etiologies of chronic cough include gastroesophageal reflux disease (GERD), upper airway cough syndrome (UACS), and asthma. However, a significant proportion of patients may have non-specific cough hypersensitivity syndrome (CHS), characterized by heightened cough reflex sensitivity. Understanding the pathophysiology of these conditions is crucial in formulating an effective diagnostic and therapeutic approach.
A systematic approach to diagnosing chronic cough includes a thorough history, physical examination, and judicious use of diagnostic tests. Initial evaluation should rule out common causes like GERD, UACS, and asthma. If the cause remains elusive, consider less common etiologies such as non-asthmatic eosinophilic bronchitis, lung cancer, and CHS. Empiric therapy trials can also aid in diagnosis.
Treatment should be etiology-specific and may involve lifestyle modifications, pharmacological therapy, or in some cases, surgical intervention. For refractory cases, newer modalities like neuromodulators or speech therapy may be considered. Importantly, patient education and reassurance play a vital role in management.
Recent research has shed light on the role of neurogenic inflammation in chronic cough, paving the way for potential new therapeutic targets. Additionally, personalized medicine approaches integrating genomics and proteomics are being explored to better understand and manage this condition.
Chronic cough is a multifaceted clinical problem requiring a systematic and comprehensive approach for effective diagnosis and management. Keeping abreast of emerging research can help clinicians navigate the complexities of chronic cough and improve patient outcomes.
1.
Is Laughter Good for Blood Glucose Control?
2.
NIH research cuts leave cancer patient facing hard choice
3.
Scientists Employ Technology to Identify Plagiarism and Forgeries in Published Studies.
4.
Ruxolitinib Reduces Acute GVHD in Transplant Patients
5.
Retired Olympic athletes at greater risk of skin cancer and osteoarthritis, research reveals
1.
The Revolutionary Treatment of Hodgkin's Lymphoma: A New Hope for the Future
2.
Unlocking the Key to Treating Lymphoma: New Innovations in Cancer Research
3.
Aging of Bone-Marrow Immune Niches: Mechanisms, Clinical Impact, and Therapeutic Horizons
4.
Biomarkers of Marrow Regenerative Capacity Following Repeated Hematopoietic Stress
5.
Consensus Recommendations for Healthy Hematologic Aging
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.
2.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
3.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
5.
Updates on the First Line Management of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation